At Manningham Medical Centre, you can find all the data about Chronix Biomedical Germany. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


Oncocyte Announces Definitive Agreement to Acquire …

    https://investors.oncocyte.com/news-releases/2021/02-02-2021-130417994
    Chronix Biomedical, Inc. is a privately held, U.S.-based molecular diagnostics company developing blood tests for use in cancer treatment and organ …

Oncocyte acquires molecular diagnostics …

    https://www.nsmedicaldevices.com/news/oncocyte-chronix-biomedical-blood-tests/
    The acquisition includes Chronix’s lab in Germany and its EU-based development and business team. (Credit: Belova59 from Pixabay) Molecular …

Chronix Biomedical GmbH Company Profile - Dun

    https://www.dnb.com/business-directory/company-profiles.chronix_biomedical_gmbh.9c61d6b1b77ade874d1ab70b4e518242.html
    Chronix Biomedical GmbH Company Profile | Göttingen, Niedersachsen, Germany | Competitors, Financials & Contacts - Dun & Bradstreet. Find company research, …

Oncocyte Agrees to Enter Licensing and Collaboration …

    https://investors.oncocyte.com/news-releases/2020/10-01-2020-130112268
    Chronix Biomedical, Inc. is a U.S.-based molecular diagnostics company developing blood tests for use in cancer treatment and organ transplantation. Chronix’s …

Oncocyte Agrees to Enter Licensing and Collaboration

    https://www.globenewswire.com/news-release/2020/10/01/2102141/0/en/Oncocyte-Agrees-to-Enter-Licensing-and-Collaboration-Agreement-with-Chronix-Biomedical.html
    Chronix has a well-established laboratory in Germany and a commercial footprint in the EU. Chronix’s EU base of laboratory operations, commercial relationship with its clinical …

Oncocyte acquires Chronix Biomedical

    https://www.massdevice.com/oncocyte-acquires-chronix-biomedical/
    Oncocyte (NSDQ:OCX) announced today that it completed its acquisition of molecular diagnostics company Chronix Biomedical. Irvine, Calif.-based Oncocyte’s …

Oncocyte Acquires Blood-Based Molecular Diagnostics …

    https://markets.businessinsider.com/news/stocks/oncocyte-acquires-blood-based-molecular-diagnostics-provider-chronix-biomedical-for-roughly-10-million-1030033683
    Oncocyte Acquires Blood-Based Molecular Diagnostics Provider, Chronix Biomedical For Roughly $10 Million Vandana Singh, Benzinga Feb. 2, 2021, 09:35 AM …

Oncocyte Announces Definitive Agreement to Acquire …

    https://www.nasdaq.com/press-release/oncocyte-announces-definitive-agreement-to-acquire-chronix-biomedical-inc.-2021-02-02
    Chronix TheraSure™ Transplant Monitor quantifies the amount of graft derived cell-free DNA in organ recipients to detect early rejection of organ transplants and …

Chronix Biomedical - Crunchbase Company …

    https://www.crunchbase.com/organization/chronix-biomedical
    Chronix Biomedical is a molecular diagnostics company developing blood tests for monitoring minimal residual disease in cancer patients. Acquired by OncoCyte San …

Chronix Biomedical Develops Organ Transplant …

    https://www.genomeweb.com/pcrsample-prep/chronix-biomedical-develops-organ-transplant-rejection-assay-bio-rad-ddpcr-platf
    Scientistsfrom molecular diagnostics firm Chronix Biomedical and University Medical Center Göttingen in Germany have developed an assay to measure circulating cell-free …



Need more information about Chronix Biomedical Germany?

At Manningham Medical Centre, we collected data on more than just Chronix Biomedical Germany. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.